FARN:LON
Faron Pharmaceuticals Oy
GBX 36.07
arrow_downward
-1.18%(-0.43) 1D
Oct 1, 5:44:12 PM GMT+1 · GBX
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for FARN...
Open
GBX 37.75
High
GBX 38.00
Low
GBX 34.00
Mkt. cap
73.18M
Avg. vol.
49.09K
Volume
95.17K
52-wk high
GBX 193.58
52-wk low
GBX 34.00
EPS
-GBX 0.10
Shares outstanding
31.03M
No. of employees
36
Open
GBX 37.75
High
GBX 38.00
Low
GBX 34.00
Mkt. cap
73.18M
Avg. vol.
49.09K
Volume
95.17K
52-wk high
GBX 193.58
52-wk low
GBX 34.00
EPS
-GBX 0.10
Shares outstanding
31.03M
No. of employees
36
News stories
From web sources and news partners
www.marketscreener.com
·
12 minutes ago
EMEA Morning Briefing : Markets Await U.S. Jobs Report
marketscreener.com
·
37 minutes ago
S&P 500 index edged higher after Stockholm Stock Exchange's close Thursday
The Motley Fool
·
12 hours ago
If a Bear Market Is Coming, History Says This Is How Long It Could Take to Recover
Profile
Faron Pharmaceuticals is a Finnish drug discovery and development company based in Turku, Finland.
The company was founded in 2003 by a group led by Markku Jalkanen, who now acts as the company's Chief Executive Officer. It specialises in the development of treatments for acute organ traumas, vascular damage and cancer immunotherapy.
Its lead product Traumakine has been developed to treat acute respiratory distress syndrome. It is currently undergoing international phase III clinical trials after an open-label, early-phase trial showed promising results in the treatment patients with ARDS. The drug is known to function by enhancing lung CD73 expression and increasing production of anti-inflammatory adenosine, such that vascular leaking and escalation of inflammation are reduced. The U.S. Food and Drug Administration FDA has accepted the proposed protocol design for the next Traumakine study in March 2020. The phase III study is a comparison of efficacy in the treatment of patients with ARDS.
In 2020 Traumakine was selected to take part in the WHO Solidarity trial and REMAP-CAP trials to find drugs for the symptoms of Covid_19. Wikipedia
About Faron Pharmaceuticals Oy